Thymic stromal lymphopoietin (TSLP) is a novel IL-7-like cytokine. Human TSLP (hTSLP) activates CD11+ dendritic cells (DCs) both to up-regulate MHC class II and costimulatory molecules CD40, CD80, and CD86 and to secrete the TH2-attracting chemokines TARC and MDC. TSLP-activated DCs induce the most marked antigen-specific CD4+, naive T-cell expansion, after which the T cells differentiate into TH2 effector cells that secrete high concentrations of interleukin (IL)-4, IL-5, IL-13, and tumor necrosis factor-alpha(TNF-alpha). hTSLP is mainly expressed by epithelial cells in allergic inflamed tissues. Our central hypothesis is that allergic insults caused by chemicals, microbes, and allergens initially trigger mucosal epithelial cells or skin keratinocytes, to produce TSLP. TSLP then activates Langerhans' cells (immature dendritic cells in epidermis), which migrate into the draining lymph nodes and prime allergen-specific na'fve T cells to expand and differentiate into proallergic TH2 effector cells. These TH2 effector T cells then produce IL-4, IL-5, and IL-13 that initiate an allergic inflammation by triggering immunoglobulin E (IgE) production, eosinophilia, and mucus production. Further investigation of the molecular mechanisms underlying the regulation of TSLP production by epithelial cells and TH2 differentiation induced by TSLP-activated DCs is essential for understanding the whole pathophysiological process underlying allergic responses, and hence for developing more effective therapies for allergic diseases.
The specific aims of this proposal are: 1. To identify the molecular triggers of TSLP production by epithelial cells and the association of these triggers with human allergic diseases; 2. To identify the molecular regulation of TSLP receptor (TSLPR) and IL-7Ralpha co-expression; 3. To elicidate the molecular mechanisms by which TSLP-activated DCs induce TH2 differentiation.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-SSS-F (01))
Program Officer
Dong, Gang
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
Other Domestic Higher Education
United States
Zip Code
Voo, Kui S; Bover, Laura; Harline, Megan L et al. (2013) Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function. J Immunol 191:3641-50
Hanabuchi, Shino; Watanabe, Norihiko; Liu, Yong-Jun (2012) TSLP and immune homeostasis. Allergol Int 61:19-25
Ito, Tomoki; Liu, Yong-Jun; Arima, Kazuhiko (2012) Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the ""Th2 code"" in dendritic cells. Allergol Int 61:35-43
Buglio, Daniela; Khaskhely, Noor M; Voo, Kui Shin et al. (2011) HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma. Blood 117:2910-7
Wang, Yui-Hsi; Voo, Kui Shin; Liu, Bo et al. (2010) A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 207:2479-91
Arima, Kazuhiko; Watanabe, Norihiko; Hanabuchi, Shino et al. (2010) Distinct signal codes generate dendritic cell functional plasticity. Sci Signal 3:ra4
Wang, Y-H; Liu, Y-J (2009) Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clin Exp Allergy 39:798-806
Fontenot, Danielle; He, Hong; Hanabuchi, Shino et al. (2009) TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells. Proc Natl Acad Sci U S A 106:16776-81
Liu, Yong-Jun (2009) TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol 101:1-25
Ito, Tomoki; Wang, Yui-Hsi; Duramad, Omar et al. (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202:1213-23